Time to detection of recurrence · adult cancer survivors from the following cancer sites: breast, colon, colorectal, endometrial, ovarian, cervical, melanoma and oesophageal
1 finding from 1 review
no estimate extracted
1691 participants
Very low
Health‐related quality of life, (at 12 months' · adult cancer survivors from the following cancer sites: breast, colon, colorectal, endometrial, ovarian, cervical, melanoma and oesophageal
Non‐specialist‐led showed no clear difference in health‐related quality of life, (at 12 months' compared with specialist‐led follow‐up after primary cancer treatment (low certainty).
1 finding from 1 review
MD 1.06
605 participants
Low
Anxiety · adult cancer survivors from the following cancer sites: breast, colon, colorectal, endometrial, ovarian, cervical, melanoma and oesophageal
Non‐specialist‐led showed no clear difference in anxiety (at 12 months' compared with specialist‐led follow‐up after primary cancer treatment (moderate certainty).
1 finding from 1 review
MD 0.03
1266 participants
Moderate
Depressive symptoms · adult cancer survivors from the following cancer sites: breast, colon, colorectal, endometrial, ovarian, cervical, melanoma and oesophageal
Non‐specialist‐led showed no clear difference in depression (at 12 months) HADS‐Depression subscale (higher scores… compared with specialist‐led follow‐up after primary cancer treatment (high certainty).
1 finding from 1 review
MD 0.03
1266 participants
High
Costs · adult cancer survivors from the following cancer sites: breast, colon, colorectal, endometrial, ovarian, cervical, melanoma and oesophageal
1 finding from 1 review
no estimate extracted
1756 participants
Very low
Overall survival · adult cancer survivors from the following cancer sites: breast, colorectal, head‐and‐neck, Hodgkin lymphoma, melanoma, non‐small cell lung…
Less intensive showed no clear difference in overall survival compared with more intensive follow‐up after primary cancer treatment (low certainty).
1 finding from 1 review
HR 1.05 [0.96, 1.14]
10726 participants
Low
Time to detection of recurrence · adult cancer survivors from the following cancer sites: breast, colorectal, head‐and‐neck, Hodgkin lymphoma, melanoma, non‐small cell lung…
Less intensive probably leads to lower time to detection of recurrence compared with more intensive follow‐up after primary cancer treatment (moderate certainty).
1 finding from 1 review
HR 0.85 [0.79, 0.92]
11276 participants
Moderate
Health‐related quality of life · adult cancer survivors from the following cancer sites: breast, colorectal, head‐and‐neck, Hodgkin lymphoma, melanoma, non‐small cell lung…
1 finding from 1 review
no estimate extracted
2742 participants
Very low
All‐cause mortality during hospital stay · people with critical limb ischaemia
1 finding from 1 review
Rate of amputation · people with critical limb ischaemia
It is very uncertain whether high cell dose changes amputation rate Assessed during in‐patient stay (Losordo 2012) compared with low cell dose (very low certainty).
1 finding from 1 review
Ulcer healing · people with critical limb ischaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Rest‐pain relief · people with critical limb ischaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Retention [ · trial participants being followed up for data collection
It is very uncertain whether monetary incentives: addition of monetary reward changes retention [ compared with usual follow‐up (very low certainty).
1 finding from 1 review
Retention [ · trial participants being followed up for data collection
Non‐monetary incentives: addition of pen showed no clear difference in retention [ compared with usual follow‐up (low certainty).
1 finding from 1 review
Retention [ · trial participants being followed up for data collection
It is very uncertain whether maintaining participant engagement: newsletter changes retention [ compared with usual follow‐up (very low certainty).
1 finding from 1 review
Retention [ · trial participants being followed up for data collection
Maintaining participant engagement: post‐it note showed no clear difference in retention [ compared with usual follow‐up (low certainty).
1 finding from 1 review
Retention [ · trial participants being followed up for data collection
Reminders: electronic reminder showed no clear difference in retention [ compared with usual follow‐up (low certainty).
1 finding from 1 review
Retention [ · trial participants being followed up for data collection
It is very uncertain whether prompts: Telephone prompt changes retention [ compared with usual follow‐up (very low certainty).
1 finding from 1 review
Retention [ · trial participants being followed up for data collection
Prompts: personalised prompt showed no clear difference in retention [ compared with usual follow‐up (low certainty).
1 finding from 1 review
Retention [ · trial participants being followed up for data collection
Monetary incentives: addition of monetary incentives may leads to higher retention [ compared with usual follow‐up (low certainty).
1 finding from 1 review